Skip to main content
. 2020 May 21;11:718. doi: 10.3389/fphar.2020.00718

Figure 3.

Figure 3

Bilobalide inhibited differentiation of M1 macrophage. (A, B) Bone marrow-derived macrophages (BMDMs) were treated with 1, 3, and 10 μM bilobalide in the presence of 10 ng/ml lipopolysaccharide (LPS) and 10 ng/ml interferon-gamma (IFN-γ) (M1) for 12 h. The expressions of major histocompatibility complex II (MHC-II) and CD11c were analyzed through flow cytometry. Data was summarized as a histogram of mean ± SEM of three independent experiments. *P < 0.05 and **P < 0.01 compared with LPS and IFN-γ group.